Zimmer Biomet (ZBH) PT Lowered to $137 at BMO Capital; 'Making Very Early Progress, Resetting the Bar'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/9/2026
- S&P 500 falls as AI worries hit software makers
- Brent crude hits six-week high near $97 as Houthi strike targets Saudi Aramco
- Qualcomm stock surges 9.5% on Amazon AI deal & 25M share warrant
- Energy stocks rise premarket as oil prices climb on Middle East supply fears
- Novartis shares plunge 10% as failed drug trial clouds growth outlook
- Harry and Meghan surprised by King Charles' letter on their status
- Citi initiates UiPath coverage with Buy rating and $23 target
- S&P 500 falls as AI worries hit software makers
- WestPark Capital Starts Akebia Therapeutics (AKBA) at Buy
- After an 18% summer selloff in chip stocks, Citi asks what comes next
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
- After-Hours Movers: WDAY, ADSK, S, RBRK, MRVL, ULTA, GAP, AFRM
- After-Hours Movers: NVDA, CRM, SNPS, CRWD, OKTA, NTNX
Zimmer Biomet (ZBH) PT Lowered to $130 at RBC Capital
April 27, 2018 9:02 AM EDTRBC Capital lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $140.00) while maintaining a Outperform rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $146 at Needham & Company
April 27, 2018 6:28 AM EDTNeedham & Company lowered its price target on Zimmer Biomet (NYSE: ZBH) to $146.00 (from $155.00) while maintaining a Strong Buy rating.
Analyst Mike Matson commented, "ZBH's 1Q18 revenue and EPS beat consensus. Management's 2018 revenue guidance was above consensus while its EPS guidance was slightly below... More
Zimmer Biomet (ZBH) PT Lowered to $133 at JMP Securities
April 27, 2018 4:04 AM EDTJMP Securities lowered its price target on Zimmer Biomet (NYSE: ZBH) to $133.00 (from $145.00) while maintaining a Market Outperform rating.
... MoreZimmer Biomet (ZBH) PT Lowered to $130 at Jefferies; 'Putting in the Bottom?'
April 26, 2018 1:44 PM EDTJefferies lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $141.00) while maintaining a Buy rating.
... MoreZimmer Biomet (ZBH) PT Raised to $117.50 at Evercore ISI
April 26, 2018 1:05 PM EDTEvercore ISI raised its price target on Zimmer Biomet (NYSE: ZBH) to $117.50 (from $115.00) while maintaining a In Line rating.
What analsyt Vijay Kumar liked:
Management is confident on the supply recovery turnaround in July that will help accelerate sales growth... MoreZimmer Biomet Holdings (ZBH) Tops Q1 EPS by 2c, Beats on Revenues
April 26, 2018 6:03 AM EDTZimmer Biomet Holdings (NYSE: ZBH) reported Q1 EPS of $1.91, $0.02 better than the analyst estimate of $1.89. Revenue for the quarter came in at $2.02 billion versus the consensus estimate of $1.98 billion.
For earnings history and earnings-related data on Zimmer Biomet Holdings (ZBH) click here.
... MoreZimmer Biomet (ZBH) PT Lowered to $130 at Guggenheim
April 24, 2018 6:17 AM EDTGuggenheim lowered its price target on Zimmer Biomet (NYSE: ZBH) to $130.00 (from $141.00) while maintaining a Buy rating.
... More